First National Bank of Omaha Lowers Stock Holdings in Balchem Co. (NASDAQ:BCPC)

First National Bank of Omaha lessened its holdings in Balchem Co. (NASDAQ:BCPC) by 1.4% during the third quarter, HoldingsChannel reports. The institutional investor owned 14,164 shares of the basic materials company’s stock after selling 208 shares during the quarter. First National Bank of Omaha’s holdings in Balchem were worth $2,493,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. nVerses Capital LLC purchased a new stake in shares of Balchem in the 3rd quarter valued at about $35,000. GAMMA Investing LLC raised its stake in Balchem by 73.4% in the third quarter. GAMMA Investing LLC now owns 841 shares of the basic materials company’s stock valued at $148,000 after purchasing an additional 356 shares in the last quarter. Blue Trust Inc. lifted its position in Balchem by 642.5% during the third quarter. Blue Trust Inc. now owns 839 shares of the basic materials company’s stock valued at $148,000 after purchasing an additional 726 shares during the last quarter. TD Asset Management Inc purchased a new position in Balchem in the 2nd quarter worth approximately $200,000. Finally, Heritage Family Offices LLP bought a new position in shares of Balchem in the 2nd quarter worth $206,000. Institutional investors own 87.91% of the company’s stock.

Balchem Trading Up 0.7 %

BCPC stock opened at $177.53 on Monday. Balchem Co. has a one year low of $131.10 and a one year high of $186.03. The company has a market capitalization of $5.77 billion, a PE ratio of 47.72, a price-to-earnings-growth ratio of 5.36 and a beta of 0.67. The company’s 50 day moving average price is $174.80 and its two-hundred day moving average price is $168.41. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.90 and a current ratio of 2.98.

Analyst Ratings Changes

BCPC has been the subject of a number of research analyst reports. HC Wainwright lifted their price objective on shares of Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a report on Monday, November 4th. StockNews.com upgraded Balchem from a “hold” rating to a “buy” rating in a report on Monday, October 28th.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.